bioprosthetic heart valve, method of manufacture thereof, method for enhancing the anti-thrombogenic qualities of biocompatibility or blood compatibility of a bioprosthetic heart valve
This disclosure encompasses a bioprosthetic heart valve having a polyphosphazene polymer such as poly[bis(trifluoroethoxy)phosphazene], which exhibits improved antithrombogenic, biocompatibility, and hemocompatibility properties. A method of manufacturing a bioprosthetic heart valve having a polyphosphazene polymer is also described.